Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1653-2022Class I

Baxter CLEARLINK System, Non-DEHP Solution Set with DUO-VENT Spike, Product Code 2R8403. An in-line injection...

Baxter Healthcare Corporation / initiated 2022-08-09 / Terminated / root cause: manufacturing process

Baxter Healthcare Corporation began a recall of Baxter CLEARLINK System, Non-DEHP Solution Set with DUO-VENT Spike, Product Code 2R8403. An in-line injection site on . FDA classified it as Class I and gives the reason as "Firm noted an increase in customer reports of leaks". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1653-2022
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Baxter Healthcare Corporation
Product
Baxter CLEARLINK System, Non-DEHP Solution Set with DUO-VENT Spike, Product Code 2R8403. An in-line injection site.
Product code
FPA Set, Administration, Intravascular
Reason for recall
Firm noted an increase in customer reports of leaks.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
Baxter notified their consignees by letter on 08/09/2022. The letter explained the issue, hazard, and provided the following instructions: "1. If no solution set leaks have been experienced, monitor the use of impacted solution sets closely (including during priming of the administration set and during bedside use) for issues as previously stated. 2. If any solution set leaks are experienced, cease use of the affected product and contact Baxter Corporate Product Surveillance at 800-437-5176 to report the complaint and to arrange for safe return of the product for further investigation. The product code and lot number can be found on the individual product pouch and carton. Please have your Baxter 8-digit ship-to account number, product code, lot number, and quantity of product to be returned ready when calling. 3. If you have unused solution sets that you would like to return, contact Baxter Healthcare Center for Service to arrange for return and credit. Baxter Healthcare Center for Service can be reached at 888-229-0001 between the hours of 7:00 am and 6:00 pm Central Time, Monday through Friday. Please have your Baxter 8-digit ship- to account number, product code, lot number, and quantity of product to be returned ready when calling. 4. Once Baxter has implemented corrective actions to resolve the issue, a follow-up notification will be sent to customers to provide additional instructions. 5. If you received this communication directly from Baxter, please acknowledge receipt by responding on our customer portal at https://BaxterFieldActionCustomerPortal.onprocess.com, even if you do not have any inventory. Log in to the portal using the account number listed in the enclosed reply form instruction sheet. Acknowledging receipt of this notification will prevent you from receiving repeat notices. If you do not complete the acknowledgement, you will receive a phone call from OnProcess Technology on behalf of Baxter to confirm your receipt of this notification. 6. I
Quantity in commerce
511,728 units
Distribution
US Nationwide Distribution
Product codes and lots
UDI/DI 00085412656649, All lots within expiry

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1653-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1653-2022Class ITerminatedVoluntary: Firm initiated